Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume 16, Issue 1, Pages -Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11882-015-0585-2
Keywords
TLR; IL-1 beta; Innate immunity; Inflammasome; Middle ear; Inflammation
Categories
Funding
- National Institutes of Health/National Institute of Deafness and Other Communication Disorders (NIH/ NIDCD) [DC000129, DC012595, DC006279]
- VA Research Services
Ask authors/readers for more resources
Otitis media (OM) is a common disease in young children, accounting for more office visits and surgeries than any other pediatric condition. It is associated with an estimated cost of five billion dollars annually in the USA. Moreover, chronic and recurrent middle ear (ME) disease leads to hearing loss during critical periods of language acquisition and learning leading to delays in reaching developmental milestones and risking permanent damage to the ME and inner ear in severe cases. Therefore, research to understand the disease pathogenesis and identify new therapeutics is important. Although OM is a multifactorial disease, targeting the molecular mechanisms that drive inflammation and OM resolution is critical. In this review, we discuss the current evidence suggesting that innate immune receptors and effectors play key roles in OM by mediating both the ME inflammatory responses and recovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available